OSI Systems
OSIS
194.05
-4.51
-2.27%
OSI Systems
US · OSIS
#2452 by market cap
Listed 1970
194.05
-4.51
-2.27%
Live - 5344 symbols - heartbeat 361s ago
· 2026-10-08 04:24
Pre-market
194.50
+0.23%
After-hours
194.05
0.00%
- Market cap
- 3.09B
- P/E (TTM)i
- 21.68
- P/Bi
- 3.71
- EPSi
- 8.95
- Div yieldi
- 0.00%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on OSIS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.25% YoY
Margins
- Gross margin
- 33.21%
- Operating margin
- 13.19%
- Net margin
- 8.66%
Key ratios & quality
- Enterprise valuei
- 3.73B
- PEG ratioi
- 1.14
- Altman Z-Scorei
- 3.14
PEG uses trailing P/E against the 3-year net income growth rate (19.01%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.17B | 1.15B | 1.18B | 1.28B | 1.54B | 1.71B | 1.79B |
| Gross profit | 430.59M | 420.64M | 419.92M | 424.43M | 430.51M | 530.46M | 587.18M | 593.09M |
| Selling & admin expenses | 262.48M | 251.96M | 240.75M | 235.55M | 228.31M | 269.73M | 290.88M | 278.39M |
| Research & development | 56.51M | 57.31M | 53.70M | 59.58M | 59.35M | 65.28M | 73.44M | 79.14M |
| Operating profit | 111.60M | 111.37M | 125.48M | 129.29M | 142.85M | 195.45M | 222.86M | 235.56M |
| Pretax profit | 86.16M | 86.12M | 98.64M | 140.16M | 115.24M | 161.21M | 186.09M | 192.75M |
| Tax | 21.37M | 10.87M | 24.59M | 24.81M | 23.46M | 33.06M | 36.46M | 38.04M |
| Net profit | 64.80M | 75.25M | 74.05M | 115.35M | 91.78M | 128.15M | 149.64M | 154.71M |
| Basic EPS | 4 | 4 | 4 | 7 | 5 | 8 | 9 | 9 |
| Diluted EPS | 3.46 | 4.05 | 4.03 | 6.45 | 5.34 | 7.38 | 8.71 | 8.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 444.35M | 504.99M | 384.62M | 464.06M | 453.25M | 484.06M |
| Gross profit | 150.29M | 168.24M | 123.19M | 151.63M | 150.32M | 167.95M |
| Selling & admin expenses | 73.25M | 74.69M | 66.96M | 70.20M | 71.49M | 69.75M |
| Research & development | 18.57M | 18.84M | 20.43M | 19.76M | 19.46M | 19.50M |
| Operating profit | 58.47M | 74.71M | 35.80M | 61.67M | 59.38M | 78.71M |
| Pretax profit | 47.99M | 65.80M | 25.68M | 48.08M | 49.22M | 69.77M |
| Tax | 6.86M | 13.05M | 5.12M | 9.38M | 9.00M | 14.53M |
| Net profit | 41.13M | 52.75M | 20.56M | 38.70M | 40.22M | 55.24M |
| Basic EPS | 2 | 3 | 1 | 2 | 2 | 3 |
| Diluted EPS | 2.40 | 3.03 | 1.18 | 2.22 | 2.33 | 3.27 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 640.90M | 617.71M | 709.40M | 746.14M | 839.90M | 1.22B | 1.42B | 1.61B |
| Cash & ST investments | 96.32M | 76.10M | 80.61M | 64.20M | 76.75M | 95.35M | 106.41M | 359.83M |
| Inventory | 273.71M | 241.23M | 294.21M | 333.91M | 338.01M | 397.94M | 407.17M | 415.56M |
| Total assets | 1.26B | 1.27B | 1.38B | 1.44B | 1.56B | 1.94B | 2.24B | 2.50B |
| Total current liabilities | 382.01M | 330.10M | 344.77M | 613.95M | 571.69M | 814.64M | 696.94M | 511.14M |
| Short-term debt | 88.80M | 59.93M | 846.00K | 304.58M | 223.08M | 392.17M | 186.13M | 2.53M |
| Long-term debt | 257.75M | 267.07M | 276.42M | 48.67M | 136.49M | 129.38M | 463.50M | 998.52M |
| Total liabilities | 713,137,000.00 | 696,389,000.00 | 744,547,000.00 | 804,726,000.00 | 829,521,000.00 | 1,072,525,000.00 | 1,290,173,000.00 | 1,669,491,000.00 |
| Total equity | 551.73M | 572.15M | 639.82M | 638.42M | 726.17M | 863.48M | 951.08M | 832.96M |
| Retained earnings | 399.54M | 474.79M | 548.84M | 663.87M | 735.96M | 861.23M | 942.25M | 852.12M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.27B | 1.42B | 1.48B | 1.69B | 1.72B | 1.61B |
| Cash & ST investments | 95.83M | 106.41M | 124.42M | 336.72M | 345.24M | 359.83M |
| Inventory | 438.95M | 407.17M | 454.03M | 452.61M | 435.29M | 415.56M |
| Total assets | 2.08B | 2.24B | 2.30B | 2.52B | 2.55B | 2.50B |
| Total current liabilities | 603.96M | 696.94M | 791.66M | 535.36M | 529.17M | 511.14M |
| Short-term debt | 164.15M | 186.13M | 257.48M | 5.05M | 3.79M | 2.53M |
| Long-term debt | 465.05M | 463.50M | 436.84M | 998.90M | 998.75M | 998.52M |
| Total liabilities | 1,201,672,000.00 | 1,290,173,000.00 | 1,353,198,000.00 | 1,676,751,000.00 | 1,660,116,000.00 | 1,669,491,000.00 |
| Total equity | 879.33M | 951.08M | 945.96M | 845.49M | 894.32M | 832.96M |
| Retained earnings | 889.51M | 942.25M | 962.81M | 861.97M | 902.19M | 852.12M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 119.11M | 129.18M | 139.07M | 63.81M | 94.81M | -87.50M | 97.59M | 275.90M |
| Depreciation & amortization | 56.23M | 49.76M | 43.86M | 38.68M | 38.51M | 42.21M | 43.58M | 42.65M |
| Free cash flow | 88.90M | 94.76M | 108.42M | 33.32M | 62.56M | -126.93M | 56.10M | 227.35M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -21.03M | -51.78M | -37.47M | -111.63M | -34.75M | 0 | -80.44M | -271.91M |
| Ending cash balance | 96.32M | 76.10M | 80.61M | 64.20M | 76.75M | 95.35M | 106.41M | 359.83M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 81.64M | 562.00K | 17.14M | 62.20M | 14.46M | 182.11M |
| Depreciation & amortization | 10.57M | 10.92M | 10.26M | 9.61M | 9.52M | 13.26M |
| Free cash flow | 72.70M | -9.71M | 5.70M | 50.64M | 2.48M | 168.54M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 0 | -147.03M | 0 | -124.88M |
| Ending cash balance | 95.83M | 106.41M | 124.42M | 336.72M | 345.24M | 359.83M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.45 | 13.39 | 12.22 | 18.05 | 13.45 | 16.12 | 16.49 | 17.34 |
| ROA %i | 5.14 | 5.94 | 5.58 | 8.16 | 6.12 | 7.34 | 7.16 | 6.52 |
| ROIC %i | 9.25 | 10.20 | 9.54 | 12.86 | 10.37 | 12.17 | 11.72 | 10.23 |
| 5-year avg ROE %i | 5.42 | 5.76 | 7.27 | 10.12 | 13.91 | 14.65 | 15.27 | 16.29 |
| EBIT margin %i | 9.12 | 9.00 | 10.06 | 12.60 | 10.58 | 12.29 | 12.70 | 12.26 |
| FCF / sales %i | 7.52 | 8.18 | 9.55 | 2.82 | 4.89 | -- | 3.27 | 12.73 |
| Current ratioi | 1.68 | 1.87 | 2.06 | 1.22 | 1.47 | 1.49 | 2.04 | 3.15 |
| Quick ratioi | 0.88 | 1.05 | 1.08 | 0.61 | 0.80 | 0.91 | 1.35 | 2.20 |
| Debt / assetsi | 27.40 | 25.78 | 20.03 | 24.48 | 23.11 | 26.94 | 28.99 | 40.00 |
| LT debt / equityi | 46.72 | 46.68 | 43.20 | 7.62 | 18.80 | 14.98 | 48.73 | 119.88 |
| Interest coveragei | 4.99 | 5.58 | 6.90 | 16.64 | 6.75 | 6.79 | 6.92 | 8.35 |
| Revenue CAGR (3Y) %i | 12.53 | 6.66 | 1.73 | 0.03 | 3.11 | 10.29 | 13.13 | 11.79 |
| Net income CAGR (3Y) %i | 35.31 | 52.84 | -- | 21.20 | 6.84 | 20.06 | 9.06 | 19.01 |
| FCF CAGR (3Y) %i | 35.59 | 32.72 | 7.42 | -27.90 | -12.93 | -- | 18.96 | 53.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.73 | 16.49 | 17.58 | 18.33 | 17.16 | 17.34 |
| ROA %i | 7.24 | 7.16 | 6.90 | 6.58 | 6.57 | 6.52 |
| ROIC %i | 11.94 | 11.72 | 11.24 | 10.66 | 10.33 | 10.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.27 | 12.70 | 12.56 | 12.30 | 12.07 | 12.26 |
| FCF / sales %i | 1.41 | 3.27 | 6.33 | 6.64 | 2.72 | 12.73 |
| Current ratioi | 2.11 | 2.04 | 1.87 | 3.15 | 3.25 | 3.15 |
| Quick ratioi | 1.27 | 1.35 | 1.20 | 2.19 | 2.30 | 2.20 |
| Debt / assetsi | 30.24 | 28.99 | 30.20 | 39.80 | 39.25 | 40.00 |
| LT debt / equityi | 52.89 | 48.73 | 46.18 | 118.14 | 111.68 | 119.88 |
| Interest coveragei | 6.41 | 6.92 | 7.00 | 6.59 | 7.44 | 8.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Security Division is the largest reported line at 69.87% of revenue, across 4 reported segments.
- Optoelectronics and Manufacturing division follows at 25.24%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Security Division69.87%
Optoelectronics and Manufacturing division25.24%
Healthcare Division9.11%
Region
United States34.29%
United Kingdom28.95%
Asia-Pacific19.56%
Other Americas11.53%
Mexico5.55%
Other Europe, Middle East and Africa4.36%
Quote time 2026-10-08 04:24:04 · For reference only, not investment advice and not tailored to your situation.